|
About us
|
How we regulate
|
Safety information
|
Committees
|
Conferences & Learning Centre |
Online services
|
Publications
|
News Centre
|
Your views
|
Main navigation 
HIV Adverse Drug Reaction Reporting Scheme
The aim of the HIV Adverse Drug Reaction Reporting Scheme is to increase knowledge about the safety of medicines used by people with HIV (AIDS).
- The scheme is an extension of the Yellow Card Scheme; for advice on what to report please see 'Reporting suspected adverse drug reactions'.
- The scheme is run in collaboration with the Medical Research Council Clinical Trials Unit.
- All healthcare professionals can report using this scheme; currently, patients should use the patient reporting Yellow Card.
Page last modified:
07 February 2008
© 2008 Crown Copyright Terms and conditions Links Freedom of information Report a suspected safety problem E-mail alerting service MHRA Portal
General enquiries: 020 7084 2000 info@mhra.gsi.gov.uk
To contact us about this website, use our feedback form.